Back to search

Switzerland· 22114003

Syntocinon 10 I.E., concentrato per soluzione iniettabile/per infusione

A oxytocin product, registered in Switzerland by CD PHARMA (SUISSE) SA and dispensed under Swissmedic category B. The same ATC class is registered in 16 of our 19 countries.

Cat B (Swissmedic)ATC H01BB02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedSyntocinon 10 I.E., concentrato per s…ATCH01BB02REGISTER NO.22114003PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Oxytocin is registered in 16 of 19 countries.

Countries holding a registration under ATC H01BB02 (oxytocin), each read from that country’s own register.

  • This record: Switzerland
  • 9 of them publish a price we can compare per daily dose

Oxytocin · ATC H01BB02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
CD PHARMA (SUISSE) SA
Country
Switzerland (CH)
ATC code
H01BB02
ATC class
Oxytocin
Defined daily dose
15 E, N
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

303 interactions on record for oxytocin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxytocin · interactions on record

303 records

  • 71 severe
  • 228 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9970ebb-f7a7-4066-a1af-ec7df2afb6f4
GET /v1/drugs/d9970ebb-f7a7-4066-a1af-ec7df2afb6f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about oxytocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.